Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases

Ann Surg Oncol. 2023 Feb;30(2):816-817. doi: 10.1245/s10434-022-12837-x. Epub 2022 Nov 16.

¹ Department of Digestive Surgery, Assistance Publique Hôpitaux de Paris, Georges Pompidou University Hospital, Université Paris Cité, Paris, France. [email protected].
² Department of Digestive Oncology, Assistance Publique Hôpitaux de Paris, Georges Pompidou University Hospital, Université Paris Cité, Paris, France.
³ Surgical Oncology Department, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France.
⁴ Department of Digestive Surgery, Assistance Publique Hôpitaux de Paris, Georges Pompidou University Hospital, Université Paris Cité, Paris, France.

No abstract available

Publication types